Glutathione reductase and thioredoxin reductase at the crossroad: The structure of Schistosoma mansoni thioredoxin glutathione reductase

Proteins: Structure, Function and Genetics

Volumn 72, Issue 3, 2008, Pages 936-945

  Angelucci, Francesco ^a   Miele, Adriana E ^a   Boumis, Giovanna ^a   Dimastrogiovanni, Daniela ^a   Brunori, Maurizio ^a   Bellelli, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Glutaredoxin; Redox detoxification pathway; Schistosomiasis; Structure based drug design; Supramolecular assembly; Thioredoxin reductase

Indexed keywords

DIMER; GLUTAREDOXIN; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; SELENOCYSTEINE; THIOREDOXIN REDUCTASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; SCHISTOSOMA MANSONI; STRUCTURE ANALYSIS;

ANAEROBIOSIS; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; FLAVIN-ADENINE DINUCLEOTIDE; GLUTATHIONE; GLUTATHIONE REDUCTASE; HUMANS; MODELS, MOLECULAR; MULTIENZYME COMPLEXES; MUTANT PROTEINS; NADH, NADPH OXIDOREDUCTASES; NADP; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SCHISTOSOMA MANSONI; SOLVENTS; STATIC ELECTRICITY; THIOREDOXIN-DISULFIDE REDUCTASE;

SCHISTOSOMA MANSONI;

EID: 47349121027     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21986     Document Type: Article

References (35)

1. WHO Expert Committee in Prevention and Control of Schistosomiasis and Soil Transmitted Helminthiasis. World Health Organ Tech Rep Ser 912, i-vi. Geneva: WHO; 2002. pp 1-57.
2. Cioli D, Pica-Mattoccia L. Praziquantel. Parasitol Res 2003;90:S3-S9.
3. Salinas G, Selkirk ME, Chalar C, Maizels RM, Fernandez C. Linked thioredoxin-glutathione systems in platyhelminths. Trends Parasitol 2004;20:340-346.
4. Kuntz A, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arner ES, Williams DL. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 2007;4:e206.
5. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003;5:145-155.
6. Gromer S, Urig S, Becker K. The thioredoxin system - from science to clinic. Med Res Rev 2004;24:40-89.
7. Sun QA, Kirnarsky L, Sherman S, Gladyshev VN. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 2001;98:3673-3678.
8. Su D, Novoselov SV, Sun QA, Moustafa ME, Zhou Y, Oko R, Hatfield DL, Gladyshev VN. Mammalian selenoprotein thioredoxin-glutathione reductase. J Biol Chem 2005;280:26491-26498.
9. Rendon JL, del Arenal IP, Guevara-Flores A, Uribe A, Plancarte A, Mendoza-Hernandez G. Purification, characterization and kinetic properties of the multifunctional thioredoxin-glutathione reductase from Taenia crassiceps metacestode (cysticerci). Mol Biochem Parasitol 2004;133:61-69.
10. Agorio A, Chalar C, Cardozo S, Salinas G. Alternative mRNAs arising from trans-splicing code for mitochondrial and cytosolic variants of Echinococcus granulosus thioredoxin Glutathione reductase. J Biol Chem 2004;278:12920-12928.
11. Otwinowski Z, Minor W. Macromolecular crystallography. Methods Enzymol 1997;276:307-326.
12. Read RJ. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr D 2001;57:1373-1382.
13. Collaborative Computational Project, Number 4. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr D 1994;50:760-763.
14. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci USA 2001;98:9533-9538.
15. Feng Y, Zhong N, Rouhier N, Hase T, Kusunoki M, Jacquot JP, Jin C, Xia B. Structural insight into poplar glutaredoxin C1 with a bridging iron-sulfur cluster at the active site. Biochemistry 2006;45:7998-8008.
16. Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson EJ. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr D 1999;55:247-255.
17. Winn M, Isupov M, Murshudov GN. Use of TLS parameters to model anisotropic displacements in macromolecular refinement Acta Crystallogr D 2001;57:122-133.
18. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 2004;60:2126-2132.
19. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 1995;252:199-208.
20. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem 1979;254:9627-9632.
21. Holmgren A, Åslund F. Glutaredoxin. Methods Enzymol 1995;252:283-292.
22. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
23. Potterton L, McNicholas S, Krissinel E, Gruber J, Cowtan K, Emsley P, Murshudov GN, Cohen S, Perrakis A, Noble M. Developments in the CCP4 molecular-graphics project. Acta Crystallogr D 2004;60:2288-2294.
24. Savvides SN, Karplus PA. Kinetics and crystallographic analysis of human glutathione reductease in complex with a xanthene inhibitor. J Biol Chem 1996;271:8101-8107.
25. Karplus PA, Schulz GE. Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 Å resolution. J Mol Biol 1989;210:163-180.
26. Fritz-Wolf K, Urig S, Becker K. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis. J Mol Biol 2007;370:116-127.
27. Urig S, Lieske J, Fritz-Wolf K, Irmler A, Becker K. Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity. FEBS Lett 2006;580:3595-3600.
28. Kuriyan J, Kong XP, Krishna TS, Sweet RM, Murgolo NJ, Field H, Cerami A, Henderson GB. X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4 Å resolution. Proc Natl Acad Sci USA 1991;88;8764-8768.
29. Nicholls A, Sharp KA, Honig B. Folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991;11:281-296.
30. Alger HM, Williams DL. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. Mol Biochem Parasitol 2002;121:129-139.
31. Nordstrand K, Slund F, Holmgren A, Otting G, Berndt KD. NMR structure of Escherichia coli glutaredoxin 3-glutathione mixed disulfide complex: implications for the enzymatic mechanism. J Mol Biol 1999;286:541-552.
32. Sun QA, Novoselov SV, Carlson BA, Hatfield DL, Gladyshev VN. Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase. Biochemistry 2005;44:14528-14537.
33. Wieles B, van Soolingen D, Holmgren A, Offringa R, Ottenhoff T, Thole J. Unique gene organization of thioredoxin and thioredoxin reductase in Mycobacterium leprae. Mol Microbiol 1995;16:921-929.
34. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res 2005;39:573-580.
35. Cioli D, Pica-Mattoccia L, Archer S. Antischistosomal drugs: past, present ... and future? Pharmacol Ther 1995;68:35-85.